Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial

PaperCitations, authors & open-access status

Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 379 citations, 2017 year and closed oa status.

379
Citations
2017
Year
closed
OA Status

Related on ScholarIQ

David Z.I. Cherney
Author
Bernard Zinman
Author
Silvio E. Inzucchi
Author
Christoph Wanner
Author
The Lancet Diabetes & Endocrinology
Journal
Diabetes Treatment and Management
Topic
470M+ articles · free account